By Jill Colvin and Alexandra Jaffe

President-elect Joe Biden on Monday received his first dose of the coronavirus vaccine on live television as part of a growing effort to convince the American public the inoculations are safe.

The president-elect took a dose of Pfizer vaccine at a hospital not far from his Delaware home, hours after his wife, Jill Biden, did the same. The injections came the same day that a second vaccine, produced by Moderna, will start arriving in states. It joins Pfizer's in the nation's arsenal against the COVID-19 pandemic, which has now killed more than 317,000 people in the United States and upended life around the globe.

“I'm ready,” said Biden, who was administered the dose at a hospital in Newark, Delaware, and declined the option to count to three before the needle was inserted into his left arm. “I’m doing this to demonstrate that people should be prepared when it’s available to take the vaccine. There’s nothing to worry about.”

The president-elect praised the health care workers and said President Donald Trump's administration “deserves some credit getting this off the ground.” And Biden urged Americans to wear masks during the upcoming Christmas holiday and not travel unless necessary.

Other top government officials last week joined the first wave of Americans to be inoculated against COVID-19 as part of the largest largest vaccination campaign in the nation's history.

Vice President Mike Pence, House Speaker Nancy Pelosi, D-Calif., Senate Majority Leader Mitch McConnell, R-Ky., and other lawmakers were given doses Friday. They chose to publicize their injections as part of a campaign to convince Americans that the vaccines are safe and effective amid skepticism, especially among Republicans.

Vice President-elect Kamala Harris and her husband are expected to receive their first shots next week.

But missing from the action has been President Donald Trump, who has spent the last week largely out of sight as he continues to stew about his election loss and floats increasingly outlandish schemes to try to remain in power. It's an approach that has bewildered some top aides who see his silence as a missed opportunity for the president, who leaves office Jan. 20, to claim credit for helping oversee the speedy development of the vaccine and to burnish his legacy.

Trump, who in the past has spread misinformation about vaccine risks, has not said when he intends to get the shot. He tweeted earlier this month that he was “not scheduled” to take it, but said he looked “forward to doing so at the appropriate time.”

The White House has said he is still discussing timing with his doctors.

Trump was hospitalized with COVID-19 in October and given an experimental monoclonal antibody treatment that he credited for his swift recovery. A Centers for Disease Control and Prevention advisory board has said people who received that treatment should wait at least 90 days to be vaccinated to avoid any potential interference.

“When the time is right, I’m sure he will remain willing to take it,” White House spokesperson Brian Morgenstern echoed Friday. “It’s just something we’re working through.”

White House press secretary Kayleigh McEnany, however, offered a different explanation for the delay. She told reporters last week that Trump was holding off, in part, “to show Americans that our priority are the most vulnerable.”

“The President wants to send a parallel message, which is, you know, our long-term care facility residents and our frontline workers are paramount in importance, and he wants to set an example in that regard,” she said.

The CDC's Advisory Committee on Immunization Practices has said the Pfizer-BioNTech vaccine, which was the first to receive authorization, “is safe and likely efficacious" for people who have been infected with COVID-19 and “should be offered regardless of history of prior symptomatic or asymptomatic SARS-CoV-2 infection.”

While there is no recommended minimum wait time between infection and vaccination, because reinfection is uncommon in the three months after a person is infected, the committee said people who tested positive in the preceding 90 days "may delay vaccination until near the end of this period, if desired.”

The panel also recommends that those who received Trump's treatment put off vaccination for at least 90 days.

“Currently, there are no data on the safety and efficacy of Pfizer-BioNTech COVID-19 vaccination in persons who received monoclonal antibodies or convalescent plasma as part of COVID-19 treatment," they wrote, recommending that vaccination "be deferred for at least 90 days, as a precautionary measure until additional information becomes available, to avoid interference of the antibody treatment with vaccine-induced immune responses.”

Surgeon General Jerome Adams cited that recommendation on CBS’s “Face the Nation” on Sunday when asked if Trump planned to receive the shot on camera.

“From a scientific point of view, I will remind people that the president has had COVID within the last 90 days. He received the monoclonal antibodies. And that is actually one scenario where we tell people maybe you should hold off on getting the vaccine, talk to your health provider to find out the right time,” Adams said.

But others, including Dr. Anthony Fauci, the nation’s top infectious diseases expert, have recommended that Trump be vaccinated without delay.

“Even though the president himself was infected, and he has, likely, antibodies that likely would be protective, we’re not sure how long that protection lasts. So, to be doubly sure, I would recommend that he get vaccinated,” he told ABC News.

___

Colvin reported from Washington. Associated Press writer Jonathan Lemire in New York contributed to this report.

Share:
More In Politics
States Turn to Unusual Solutions as Schools Face Staffing Shortages
With an increasing number of teachers and staff calling out sick by the day, the state of Oklahoma is turning to an unusual solution. Republican Governor Kevin Stitt has issued an executive order that permits state employees to work as substitute teachers. Shaily Baranwal, founder and CEO of Elevate K-12, joins Cheddar News to discuss.
Possible Cracks Between U.S. and Allies on Issue of Ukraine and Russia
On Thursday, Secretary of State Antony Blinken addressed the stance of the U.S. and its allies should Russia make any forays into Ukraine, a seeming response to President Biden's remarks that should Putin engage in something short of a full invasion, there might be some indecision among allied nations regarding what to do. Ariel Cohen, a senior fellow at the think tank Atlantic Council, joined Cheddar to discuss the difficulty faced by Blinken wrangling unity as tensions run high in the region. "There'll be a smaller incursion, and the president implied, there'll be a weaker response because our European allies have created this horrible situation where they are dependent on Moscow for their gas supply," Cohen explained.
Biden Approval Rating Tanking at One-Year Mark Over Issues Like Inflation
During a nearly two-hour press conference on Wednesday, President Biden spoke on his accomplishments and challenges from the first year of his presidency, and what his administration hopes to accomplish in the coming year. However, his approval ratings are underwater as COVID remains a big concern for voters — as does inflation, noted Tom Bevan, co-founder and president of polling aggregator RealClearPolitics. "The public thinks [inflation] is priority number one, and the administration is concerned about it, they talk about it, but they're not spending enough time on it as far as the public is concerned," said Bevan.
Behind Australian Judges Ruling for Allowing Novak Djokovic Deportation
The drama surrounding tennis star Novak Djokovic continues after he was deported from Australia over the weekend due to the nation's COVID-19 vaccine requirements. Djokovic was forced to leave the country on the eve of what was to be his first match in defense of his Australian Open title after three judges ruled in favor of his removal and revealed their reasoning for doing so. Adding to his woes, a law recently passed in France is putting his chances of defending his French Open title in jeopardy. The director of Marist's Center for Sports Communication, Jane McManus, joined Cheddar to discuss the ongoing fallout.
Louisiana Senate Candidate on Smoking Weed in His Campaign Ad
As the midterm elections get ever closer, candidates have been getting creative with their campaigns to stick out and to connect with voters. Gary Chambers, a Democratic candidate for the U.S. Senate from Louisiana, has definitely attracted attention with an advertisement featuring him smoking a blunt, making a point about the inequity of anti-cannabis laws. "We wanted to bring the seriousness of the moment," he said of the ad. "But we also wanted to make sure that people understand that there are 19 states that are legal right now but Black people and brown people are being over-incarcerated in mostly Southern and Midwestern states in America for cannabis possession."
TLDR Act Provides the 'TLDR' on Sites' Terms of Service
If some members of Congress have their way, there might finally be a 'TLDR' on sites' terms of service, introduced by the terms-of-service labeling, design, and readability act – or TLDR for short. With this act, users will actually understand what they're agreeing to or the many ways in which their data is being used before pressing 'accept.' J.D. sat down with co-sponsor of the bill and Senator Bill Cassidy, to discuss.
All Eyes on Biden: Amid Inflation, Pandemic, How Can President Push Agenda While His Party Controls Washington?
President Joe Biden's first year in office is wrapping up. What has he achieved, and what else remains on the table while the Democrats have control of Washington? Amid an ongoing pandemic and rising inflation, Biden's approval rating is at an all-time low and his party is plagued by infighting. Will he be able to continue pushing key parts of his agenda? Paul Glastris, former Bill Clinton speechwriter & Editor-in-chief of 'Washington Monthly,' joins Cheddar News' Closing Bell to discuss the president's achievements in his first year, where he's fallen short, and what he must do in order to get more of his agenda signed into law.
Senate Bills to Reign in Big Tech Anticompetitive Practices Could Hurt Consumers
Tech giants Meta, Amazon, Alphabet, and Apple are faced with a bipartisan antitrust legislation effort underway in the Senate Judiciary Committee. The companies stand accused of promoting their own goods and services over smaller competitors on their platforms, holding too much monopolistic power via their app stores and services. Adam Kovacevich, founder and CEO of Chamber of Progress, a technology industry trade group, joined Cheddar to argue that the bills that are being debated currently could end up hurting consumers, rather than helping.
Load More